-
After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease
01 Mar 2019 00:35 GMT
… about $65 million in an initial public offering in October just 19 months … took it from inception to IPO in less than two years … head of corporate development at Ambit Biosciences.
(BioMed was acquired in 2016 …
-
BioMarin Announces Governance Enhancements and Value Creation Initiatives
21 Dec 2023 10:20 GMT
… Chief Executive Officer through its initial public offering (IPO) to its eventual acquisition by … of Ambit Biosciences, where she helped lead the company's IPO and …
-
Tyra Biosciences Announces Planned Chief Financial Officer Transition
02 Nov 2022 00:00 GMT
… of Ambit Biosciences, where he helped lead the company through its initial public offering and …
-
Capstan Therapeutics Announces Appointment of Athena Countouriotis, M.D., as Board Chair and Strengthens Leadership Team with Key Appointment
12 Oct 2022 10:41 GMT
… and Ambit Biosciences. At Ambit she helped lead the company’s initial public offering and …
-
Recludix Pharma Announces the Appointment of Seasoned Biotech Leader Athena Countouriotis, M.D., as the Chairperson of the Board of Directors
13 Sep 2022 12:00 GMT
… chief executive officer through its IPO to its eventual acquisition by … officer of Ambit Biosciences, where she helped lead the company’s initial public offering and …
-
SpringWorks Therapeutics Appoints Alan Fuhrman to Its Board of Directors
30 Aug 2019 19:46 GMT
… of Ambit Biosciences, where he helped lead the company through its initial public offering and …
-
Poseida Therapeutics Appoints Marcy Graham as Vice President, Corporate Affairs
09 Oct 2018 12:00 GMT
… the latter public with an initial public offering in 2015. Previously, Ms. Graham … for Ambit Biosciences, where she directed communications strategy around the company’s initial public offering …